How to Help Your Patients Find Alrex in Stock: A Provider's Guide

How to Help Your Patients Find Alrex in Stock: A Provider's Guide

Prescribing Alrex (Loteprednol Etabonate 0.2%) for seasonal allergic conjunctivitis should be the easy part. But increasingly, providers are hearing from patients that they can't fill their prescription because their pharmacy doesn't have it in stock. This guide provides a practical, step-by-step approach to helping your patients access Alrex or an appropriate alternative.

Current Availability Landscape

Understanding the current market dynamics is essential for setting patient expectations:

• Brand-name Alrex is still manufactured by Bausch + Lomb but is stocked at fewer retail pharmacy locations than in previous years
• Generic Loteprednol Etabonate 0.2% has become the default product at most pharmacies and is widely available through all major wholesalers
• No formal shortage exists — Alrex is not on the FDA Drug Shortage list as of March 2026
• Seasonal variability is a factor — availability tightens during spring and fall allergy peaks

The bottom line: your patients can almost certainly get Loteprednol Etabonate 0.2% filled, but they may need guidance on how to navigate the process — especially if the prescription is written for brand-name Alrex.

Why Patients Can't Find Alrex

When patients report they can't find Alrex, the reasons typically fall into a few categories:

Pharmacy Stocking Decisions

Most chain pharmacies have transitioned from stocking brand-name Alrex to the generic. If the prescription includes a "dispense as written" (DAW) designation, the pharmacy cannot substitute the generic, and the patient leaves empty-handed.

Low Volume at Individual Stores

Ophthalmic corticosteroids are not high-volume items at most retail pharmacies. A given CVS or Walgreens location may not carry any Loteprednol products if they don't dispense them regularly. This is especially true for stores not located near ophthalmology or optometry practices.

Insurance and Cost Barriers

Even when the medication is physically available, patients may encounter insurance-related barriers:

• Prior authorization requirements
• Step therapy mandates (requiring trial of OTC antihistamines first)
• High copays or non-formulary status for brand-name Alrex
• Sticker shock from cash prices ($200-$262 for brand, $80-$132 for generic)

What Providers Can Do: 5 Steps

Step 1: Prescribe Generically When Possible

The single most impactful change is to prescribe Loteprednol Etabonate Ophthalmic Suspension 0.2% rather than brand-name Alrex. This allows the pharmacy maximum flexibility to fill from available stock. Unless you have a specific clinical concern about a particular generic manufacturer's formulation, generic prescribing will solve most access problems.

Practical tip: If your EMR defaults to brand-name Alrex, update your favorites/quick-order sets to default to generic Loteprednol Etabonate 0.2%.

Step 2: Document Step Therapy Compliance

Many payers require documentation that the patient has tried and failed OTC antihistamine eye drops before covering a corticosteroid. Proactively documenting this in your notes — even at the visit where you first recommend OTC drops — will streamline prior authorization if and when you need to escalate to Alrex.

Documentation template: "Patient has used OTC olopatadine (Pataday) for [duration] with inadequate symptom control. Continuing to experience significant [itching/redness/swelling]. Escalating to Loteprednol Etabonate 0.2% for short-term anti-inflammatory management."

Step 3: Direct Patients to Medfinder

When a patient reports difficulty filling their prescription, recommend Medfinder. This tool allows patients to search for Alrex or generic Loteprednol Etabonate 0.2% and see which pharmacies near them have it in stock.

Practical tip: Include Medfinder in your post-visit patient instructions or handouts for allergy prescriptions. A simple note like "If your pharmacy doesn't have this medication, check medfinder.com to find it in stock nearby" can prevent phone calls back to your office.

Step 4: Leverage Independent Pharmacies

Build relationships with local independent pharmacies, especially those near your practice. Independent pharmacies often:

• Carry a wider range of ophthalmic products
• Can order from multiple distributors for faster fulfillment
• Provide more personalized service to patients
• Are willing to stock medications they know your practice prescribes regularly

Consider maintaining a short list of recommended pharmacies for specialty ophthalmic prescriptions that you can share with patients.

Step 5: Keep Samples for Bridging

If your practice receives samples from Bausch + Lomb, keep a supply of Alrex samples on hand. These can serve as a bridge for patients who need immediate treatment while they locate a pharmacy with stock. Even a few days of sample medication can make the difference between a patient suffering through allergy symptoms and getting timely relief.

Alternative Medications to Consider

When Alrex or generic Loteprednol 0.2% is genuinely unavailable, or when clinical circumstances warrant a different approach, consider these alternatives:

For Mild Symptoms

• Pataday (Olopatadine) — OTC antihistamine/mast cell stabilizer, once-daily dosing, well-tolerated, $15-$25 OTC
• Zaditor (Ketotifen) — OTC antihistamine, twice-daily dosing, very affordable at $8-$15

For Moderate to Severe Symptoms

• Lotemax (Loteprednol Etabonate 0.5%) — Higher-concentration Loteprednol for more significant inflammation; available as suspension, gel (Lotemax SM), and ointment
• Pred Forte (Prednisolone Acetate 1%) — Traditional ophthalmic corticosteroid; more potent but higher IOP risk; widely available generic at $15-$40; requires more vigilant IOP monitoring

For a detailed comparison of alternatives, see our guide to Alrex alternatives.

Workflow Tips for Your Practice

Integrating these strategies into your daily workflow can reduce patient callbacks and improve satisfaction:

1. At the point of prescribing: Mention to the patient that the medication may not be at every pharmacy. Hand them a Medfinder recommendation or independent pharmacy referral.
2. In the EMR: Set up a standard after-visit summary (AVS) that includes pharmacy search tips for ophthalmic prescriptions.
3. Front desk protocol: Train staff to direct patients who call about pharmacy availability issues to Medfinder at medfinder.com/providers rather than having clinical staff field these calls.
4. Prior auth readiness: Keep a template for Loteprednol Etabonate prior authorizations that includes step therapy documentation, clinical rationale, and the IOP safety advantage of Loteprednol over traditional steroids.
5. Quarterly review: Check with your most-used pharmacies periodically to confirm they stock Loteprednol Etabonate 0.2%. If they don't, a quick conversation with the pharmacy manager can often get it added to their auto-order list.

Final Thoughts

Helping patients access Alrex in 2026 requires a proactive approach. By prescribing generically, documenting step therapy compliance, and directing patients to real-time availability tools like Medfinder, you can significantly reduce the friction your patients experience when filling their prescriptions.

The medication access challenge isn't unique to Alrex — it's a growing issue across many ophthalmic specialty products. Building workflows that anticipate these challenges will benefit your practice and your patients well beyond allergy season.

Related provider resources:

• Alrex Shortage: What Providers Need to Know in 2026
• How to Help Patients Save Money on Alrex
• How Does Alrex Work? Mechanism of Action Explained